Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-24-130162
Filing Date
2024-12-19
Accepted
2024-12-19 16:48:14
Documents
4
Period of Report
2025-02-28

Document Format Files

Seq Description Document Type Size
1 PRE 14A tm2431486-1_pre14a.htm PRE 14A 170073
2 GRAPHIC lg_transcodetheraptm-4c.jpg GRAPHIC 10109
3 GRAPHIC px_24transcodepxy01pg01-bw.jpg GRAPHIC 258368
4 GRAPHIC px_24transcodepxy01pg02-bw.jpg GRAPHIC 228458
  Complete submission text file 0001104659-24-130162.txt   796064
Mailing Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109 857-301-6857
Transcode Therapeutics, Inc. (Filer) CIK: 0001829635 (see all company filings)

IRS No.: 811065054 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-40363 | Film No.: 241563980
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)